Results 31 to 40 of about 13,683 (246)

AB0703 WHICH OF THE ASDAS OR BASDAI CORRELATES BETTER WITH PHYSICIAN GLOBAL ASSESSMENT? [PDF]

open access: bronzeAnnals of the Rheumatic Diseases, 2020
Background: Ankylosing Spondylitis Disease Activity score (ASDAS) was developed because of the limitations of Bath Ankylosing Spondylitis Disease Index (BASDAI) of being totally patient-derived with limited face and construct validity. ASDAS includes inflammatory markers that were aimed to increase its face validity by representing a different ...
Kaouther Maatallah   +4 more
openalex   +2 more sources

The Pharmacy of the Specialized Component of Pharmaceutical Policy of the 9th Regional Health Department of the State of Paraná and the Treatment of Ankylosing Spondylitis [PDF]

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2022
The objective of this study was to trace the profile of patients with Ankylosing Spondylitis treated at the Pharmacy of the 9th Regional Health Department of Paraná and evaluate the relationship between pharmacological treatment, quality of life and ...
Letycia Longhi Scolaro   +2 more
doaj   +1 more source

Clinical Response to Adalimumab Therapy and Its Determinants in Patients With Radiographic Axial Spondyloarthritis: A Prospective Real-World Study in Taiwan. [PDF]

open access: yesInt J Rheum Dis
ABSTRACT Aim To investigate the clinical response to adalimumab (ADA) in patients with active radiographic axial spondyloarthritis (r‐axSpA) in Taiwan. Methods In this real‐world study, patients with r‐axSpA, starting ADA therapy, were enrolled and followed up every 12 weeks for 48 weeks.
Liu FC   +14 more
europepmc   +2 more sources

A24: Validation of BASDAI and BASFI in Children with Spondyloarthritis [PDF]

open access: yesArthritis & Rheumatology, 2014
Background/Purpose:Juvenile‐onset Spondyloarthritis (JSpA), referred to as Enthesitis‐Related Arthritis (ERA) subtype under the International League of Associations for Rheumatology (ILAR) classification is characterized by arthritis and enthesitis largely affecting the lower limbs.
Alisa C. Rachlis   +9 more
semanticscholar   +3 more sources

POS0997 PERFORMANCE OF ASDAS VERSUS BASDAI DURING PREGNANCY [PDF]

open access: yesAnnals of the Rheumatic Diseases, 2021
Background: Disease activity in patients with axial spondyloarthritis (axSpA) can be measured by BASDAI and ASDAS. Both instruments were validated in non-pregnant patients with cutoff values for active diseases. In pregnant women with axSpA, however, BASDAI and ASDAS scores might be biased by signs and symptoms of pregnancy itself.
F. Foerger, P. Fischer, Astrid Zbinden
openaire   +1 more source

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set : translation and cross-cultural adaptation into 15 languages [PDF]

open access: yes, 2016
Introduction: The Assessments of SpondyloArthritis international society Health Index (ASAS HI) measures functioning and health in patients with spondyloarthritis (SpA) across 17 aspects of health and 9 environmental factors (EF).
Bautista-Molano, W   +26 more
core   +23 more sources

Correlation of neutrophil-lymphocyte ratio, plateletlymphocyte ratio and mean platelet volume with disease activity in patients with ankylosing spondylitis

open access: yesInternational Journal of Medical Biochemistry, 2022
INTRODUCTION: The indices that are currently used to determine the disease activity in patients with ankylosing spondylitis (AS) are either patient- or physician-oriented.
Pulin Kumar Gupta   +8 more
doaj   +1 more source

Comparative Analysis Between the Basdai and Mini-Basdai Indices in Patients with Ankylosing Spondylitis

open access: goldInternal Medicine, 2018
Abstract Objectives. The aim of this paper is to compare the degree of accuracy between the BASDAI and mini-BASDAI indices in assessing the activity of ankylosing spondylitis (AS), especially in patients without peripheral manifestations. Materials and method. Our cross-sectional study
Sandra Burtică   +2 more
openalex   +3 more sources

THU0665 Can one give up basdai in favor of asdas in monitoring spondyloarthritis patients on biologics? [PDF]

open access: bronzeAnnals of the Rheumatic Diseases, 2017
Cristian Cobilinschi   +2 more
openalex   +3 more sources

Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study

open access: yesRheumatology and Therapy, 2023
Introduction Guselkumab previously showed greater improvements versus placebo in axial symptoms in patients with psoriatic arthritis (PsA) (assessed by Bath Ankylosing Spondylitis Disease Activity Index [BASDAI] and Ankylosing Spondylitis Disease ...
Philip J. Mease   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy